Survival rate of gastric cancer

Update Date: 2023-12-05 Source: Network

summary

My aunt was diagnosed with gastric cancer in a physical examination last year and has been receiving treatment since. This year, the disease is getting worse and worse, with severe gastric bleeding and vomiting as soon as you eat. Next, let me talk about the survival rate of gastric cancer.

Survival rate of gastric cancer

First: it mainly depends on whether the patient can be treated in time and the effect of treatment. If the patient is found early and the metastasis is still a single lesion, the patient's life can be effectively prolonged after chemotherapy. The time varies from 2 to 10 years. The specific time depends on the treatment effect of the patient.

Second, there is no fixed time standard for how long the recurrence of gastric cancer can live. The survival time of patients with advanced gastric cancer is related to the pathological type, stage, physical function, treatment method and other factors. Because of the strong concealment of gastric cancer, it is often found in the middle and advanced stage. At this time, patients often have panic psychology, and it is easy to think about how long the recurrence of gastric cancer can live.

Third, the 5-year survival rate of early gastric cancer after resection is about 80%. Radiotherapy and chemotherapy, DC-CIK biological immunotherapy and other means can be used to prevent recurrence and metastasis within a certain period of time after operation. For patients with recurrent gastric cancer, DC-CIK biological immunotherapy can effectively control the recurrence symptoms of gastric cancer patients and prolong the life time of patients.

matters needing attention

It is suggested that patients should try their best to improve their own immunity and tolerance to treatment during treatment. In this regard, it is recommended that patients should supplement selenium with selenium Weikang chewable tablets. Selenium supplementation can effectively activate the patient's immune system, enhance the patient's immunity and tolerance to treatment.